相关实验视频
Updated: Jan 11, 2026
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.5K
炎症性肠病和炎症性肠病:最近的流行病学见解,病变发生和治疗方法
Katelyn Downey1, Richard Zhang2, Alex G Ortega-Loayza1
1Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
Journal of inflammation research
|November 19, 2025
概括
炎症性肠病 (IBD) 患者的炎症性肠病 (PG) 很少见,症状和治疗方法各异. 对这种复杂的疾病进行标准化,基于证据的护理需要进一步的研究.
科学领域:
- 皮肤病学和胃肠病学
- 免疫皮肤学 免疫皮肤学
- 炎症性肠道疾病研究研究
背景情况:
- 炎症性性皮肤病 (PG) 是一种罕见的中性友皮肤病,经常与炎症性肠病 (IBD) 相关.
- 了解IBD患者PG的流行病学,临床表现和治疗对于改善患者的治疗结果至关重要.
- 现有的知识是基于案例报告,队列研究和机制研究.
研究的目的:
- 提供关于IBD患者PG的当前知识的全面叙事审查.
- 从已发表的文献中综合人口,临床和治疗趋势.
- 识别知识上的差距,并强调未来研究的需要.
主要方法:
- 基于人口,大队列和机理学研究的系统审查.
- 深入分析了115个已发表的病例报告和PG和IBD患者的病例系列.
- 人口,临床和治疗数据的综合.
主要成果:
- 在IBD患者中的PG通常影响中年成人,女性占主导地位.
- 大多数PG病例发生在IBD诊断后,尽管有些人同时或之前存在.
- 临床特征多样化,使诊断复杂化;治疗反应有很大差异,往往需要个性化,多种药物的方法.
- 生物药物越来越多地被利用,针对共享的炎症途径,但缺乏标准化的治疗方法.
结论:
- 在IBD患者中的PG呈现异质,需要个性化治疗策略.
- 共有的炎症途径,包括Th17/Th1免疫失调和IL-1β/IL-36信号传递,都与病变发生有关.
- 需要进行纵向的受控研究,以建立基于证据的标准化治疗指南.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
932
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
932
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
876
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
876
01:17Chronic Bowel Disorders: Introduction
735
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
735
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
620
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
620
01:29Inflammatory Bowel Disease IV: Pharmacological Management
452
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
452
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
469
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
469